tailieunhanh - A phase II study of Epirubicin in oxaliplatinresistant patients with metastatic colorectal cancer and TOP2A gene amplification

The overall purpose of this study is to provide proof of concept for introducing the anthracycline epirubicin as an effective, biomarker-guided treatment for metastatic colorectal cancer (mCRC) patients who are refractory to treatment with oxaliplatin-based chemotherapy and have TOP2A gene amplification in their tumor cells. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN